INDIAN generics giant Sun
Pharma has announced the
acquisition of 14 established
prescription brands from Novartis
in Japan, in a deal worth US$293
million.
Novartis will continue to
distribute the brands for a certain
period pending transfer of all
marketing authorisations to Sun
Pharma, after which they will
be “marketed by a reliable and
established local marketing partner
under the Sun Pharma label”.
The brands have combined annual
revenues of about US$160 million
and address medical conditions
across several therapeutic areas.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Mar 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.